Jan Pawlak
- Toxicology top 1%
- Organic Chemistry top 10%
- Carbohydrate Chemistry and Synthesis 4
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis 4
- Biotechnology top 10%
-
- Chemical Synthesis and Analysis 5
- Cancer therapeutics and mechanisms 4
-
- Analytical Chemistry and Chromatography 5
- Molecular spectroscopy and chirality 4
-
- Cancer Treatment and Pharmacology 4
-
- Calpain Protease Function and Regulation 2
Jan Pawlak
30 papers receiving 783 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Toxicology 126
- Organic Chemistry 301
- Pharmacology 156
- Biotechnology 62
- Molecular Biology 464
Countries citing papers authored by Jan Pawlak
This map shows the geographic impact of Jan Pawlak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Pawlak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Pawlak more than expected).
Fields of papers citing papers by Jan Pawlak
This network shows the impact of papers produced by Jan Pawlak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Pawlak. The network helps show where Jan Pawlak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan Pawlak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 5 | |
| 2 | 2015 | 14 | |
| 3 | 2012 | 6 | |
| 4 | The Structure of Levorin A3, a Minor Component of Levorin Complex | 2005 | 3 |
| 5 | The structure of nystatin A2 | 2005 | 2 |
| 6 | 2005 | 10 | |
| 7 | 1996 | 2 | |
| 8 | 1995 | 28 | |
| 9 | 1995 | 22 | |
| 10 | 1995 | 4 | |
| 11 | 1993 | 24 | |
| 12 | 1989 | 21 | |
| 13 | 1988 | 10 | |
| 14 | 1987 | 62 | |
| 15 | Isolation and Structure of a Covalent Cross-Link Adduct Between Mitomycin C and DNAbreakdown → | 1987 | 390 |
| 16 | 1983 | 11 | |
| 17 | The structure of lienomycin, a pentaene macrolide antitumor antibiotic. I. The structure of the carbon skeleton and the location of functionalities.:I. THE STRUCTURE OF THE CARBON SKELETON AND THE LOCATION OF FUNCTIONALITIES | 1980 | 4 |
| 18 | The preparation of N-glycosyl derivatives of polyene macrolide antibiotics and their comparative antifungal activities. | 1980 | 4 |
| 19 | 1979 | 29 | |
| 20 | 1975 | 28 |
About Jan Pawlak
Jan Pawlak is a scholar working on Spectroscopy, Toxicology and Organic Chemistry, having authored 30 papers that have together received 814 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (5 papers), Analytical Chemistry and Chromatography (5 papers), Microbial Natural Products and Biosynthesis (4 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), Molecular spectroscopy and chirality (4 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Calpain Protease Function and Regulation (2 papers). The work is most often cited by research in Toxicology (126 citations), Organic Chemistry (301 citations) and Pharmacology (156 citations). Jan Pawlak has collaborated with scholars based in Poland, Italy and Japan. Frequent co-authors include Koji Nakanishi, Edward Borowski, Maria Tomasz, Gregory L. Verdine, Roselyn Lipman, Dondapati Chowdary, Paweł Sowiński, Pierluigi Gariboldi, Takashi Iwashita and Jerzy Golik. Their work appears in journals such as Science, Journal of the American Chemical Society and The Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.